<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 9.4: Thyroid-Immune Interplay: Beyond TSH</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/PURPLE theme for Neuro-Endocrine */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #2563eb;
            margin: 35px 0 15px 0;
        }

        /* Paragraphs & Lists */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .content-list {
            font-size: 17px;
            margin: 20px 0;
            padding-left: 24px;
        }

        .content-list li {
            margin-bottom: 14px;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: #3b82f6;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Stats Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #1e40af 100%);
            padding: 35px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(160px, 1fr));
            gap: 25px;
            text-align: center;
        }

        .stat-number {
            font-size: 36px;
            font-weight: 700;
            display: block;
            margin-bottom: 5px;
        }

        .stat-label {
            font-size: 13px;
            opacity: 0.9;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Comparison Table */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f1f5f9;
            padding: 15px;
            text-align: left;
            font-weight: 600;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fffbeb;
            border: 2px solid #fbbf24;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #fef3c7;
        }

        .reveal-btn {
            background: #d97706;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #fef3c7;
            border-radius: 8px;
            color: #92400e;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f8fafc;
            border: 1px solid #e2e8f0;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #ffffff;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 40px;
        }

        /* Classes for specific styling */
        .stat-highlight { font-weight: 700; color: #1e3a8a; }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 9: The Neuro-Endocrine-Immune Axis</p>
            <h1 class="lesson-title">Lesson 9.4: Thyroid-Immune Interplay: Beyond TSH</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 4 of 4</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#molecular-mimicry"><span class="section-num">1</span>Molecular Mimicry</a></li>
                <li><a href="#immune-modulation"><span class="section-num">2</span>T3 and Immune Cells</a></li>
                <li><a href="#ntis"><span class="section-num">3</span>Non-Thyroidal Illness Syndrome</a></li>
                <li><a href="#nutrients"><span class="section-num">4</span>Nutrient Synergies</a></li>
                <li><a href="#testing"><span class="section-num">5</span>The Full Thyroid Panel</a></li>
                <li><a href="#calm-integration"><span class="section-num">6</span>C.A.L.M. Integration</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze why the thyroid gland is the primary target for autoimmune cross-reactivity.</li>
                <li>Explain the role of Triiodothyronine (T3) in T-cell maturation and NK cell cytotoxicity.</li>
                <li>Identify the mechanisms of Non-Thyroidal Illness Syndrome (NTIS) in chronic inflammation.</li>
                <li>Evaluate the synergistic relationship between Selenium, Iodine, and Zinc in thyroid homeostasis.</li>
                <li>Interpret advanced thyroid biomarkers (Reverse T3, TPOAb, TgAb) beyond standard TSH screening.</li>
            </ul>
        </div>

        <h2 id="molecular-mimicry">1. The Vulnerable Gland: Molecular Mimicry</h2>
        <p>In our journey through the Neuro-Endocrine-Immune (NEI) axis, we have explored how the nervous system and HPA axis dictate immune behavior. However, the <span class="highlight">thyroid gland</span> acts as the metabolic thermostat for this entire system. It is not a coincidence that autoimmune thyroid disease (Hashimotoâ€™s and Gravesâ€™) accounts for the vast majority of autoimmune cases worldwide.</p>
        
        <p>The thyroid's unique susceptibility stems from <span class="highlight">molecular mimicry</span>. Certain environmental triggersâ€”specifically pathogens like <i>Yersinia enterocolitica</i> and dietary proteins like glutenâ€”possess amino acid sequences that closely resemble thyroid-specific proteins, such as Thyroperoxidase (TPO) and Thyroglobulin (Tg).</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <span class="stat-number">90%</span>
                    <span class="stat-label">Hypothyroidism caused by Autoimmunity</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">8:1</span>
                    <span class="stat-label">Female to Male Prevalence Ratio</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">50%</span>
                    <span class="stat-label">Increased risk with Gluten Sensitivity</span>
                </div>
            </div>
        </div>

        <p>When the immune system encounters these triggers in a state of intestinal permeability (the "A" in C.A.L.M.), it mounts an attack. Because of the structural similarity, the antibodies generated "miss" their target and begin destroying thyroid tissue. This is why, in the <span class="highlight">C.A.L.M. Autoimmune Protocolâ„¢</span>, we emphasize that thyroid health begins in the gut, not the gland.</p>

        <h2 id="immune-modulation">2. Thyroid Hormones as Immune Modulators</h2>
        <p>Thyroid hormones, particularly <span class="highlight">Triiodothyronine (T3)</span>, are not merely metabolic regulators; they are potent immunomodulators. Receptors for T3 are found on almost all immune cells, including T-cells, B-cells, macrophages, and Natural Killer (NK) cells.</p>

        <h3>T-Cell Differentiation and Maturation</h3>
        <p>T3 is essential for the proper development of the thymus gland, the "training ground" for T-cells. Low T3 levels lead to thymic atrophy, resulting in a reduced pool of <span class="highlight">T-regulatory (Treg) cells</span>. As we learned in Module 1, Tregs are the "peacekeepers" of the immune system. Without sufficient T3, the balance shifts toward pro-inflammatory Th17 cells, accelerating the autoimmune cycle.</p>

        <h3>Natural Killer (NK) Cell Activation</h3>
        <p>Research has demonstrated that T3 enhances the cytotoxic activity of NK cells. These cells are our first line of defense against virally infected cells and tumors. A 2021 study published in <i>Frontiers in Endocrinology</i> found that patients with subclinical hypothyroidism had significantly lower NK cell activity, which normalized only after thyroid hormone replacement reached optimal (not just "normal") levels.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Normal TSH" Paradox</p>
                    <p class="subtitle">Clinical Application of NEI Axis Principles</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah J., 34</h4>
                        <p>Symptoms: Fatigue, hair loss, brain fog, recurrent viral infections.</p>
                    </div>
                </div>
                <p>Sarah was told her thyroid was "fine" because her TSH was 3.2 mIU/L (within the conventional range of 0.4â€“4.5). However, her symptoms persisted. Applying the C.A.L.M. methodology, a full panel was run.</p>
                <ul>
                    <li><strong>TSH:</strong> 3.2 mIU/L (Functional optimal < 2.0)</li>
                    <li><strong>Free T3:</strong> 2.4 pg/mL (Low-end of range)</li>
                    <li><strong>TPO Antibodies:</strong> 145 IU/mL (Positive/Elevated)</li>
                    <li><strong>Reverse T3:</strong> 28 ng/dL (Significantly elevated)</li>
                </ul>
                <p><strong>Outcome:</strong> Sarah wasn't suffering from primary gland failure; she had <span class="highlight">HPA-Thyroid-Immune dysregulation</span>. Her body was shunting T4 into Reverse T3 due to chronic inflammatory stress. By addressing the "C" (Contain Inflammation) phase of the protocol, her TPO antibodies dropped to 22 IU/mL in 4 months, and her Free T3 rose to 3.4 pg/mL without medication.</p>
            </div>
        </div>

        <h2 id="ntis">3. Non-Thyroidal Illness Syndrome (NTIS)</h2>
        <p>In the context of autoimmunity, we frequently encounter <span class="highlight">Non-Thyroidal Illness Syndrome (NTIS)</span>, also known as "Euthyroid Sick Syndrome." This is a physiological adaptation where the body deliberately slows metabolism during periods of severe stress or systemic inflammation.</p>

        <p>The mechanism involves the <span class="highlight">Deiodinase enzymes</span>. These enzymes are responsible for converting T4 (inactive) into T3 (active) or Reverse T3 (inactive/blocking).
        <ul class="content-list">
            <li><strong>D1 and D2:</strong> Convert T4 to T3. These are inhibited by inflammatory cytokines like <span class="stat-highlight">IL-6 and TNF-alpha</span>.</li>
            <li><strong>D3:</strong> Converts T4 into Reverse T3. This enzyme is <i>upregulated</i> by inflammation.</li>
        </ul>
        </p>

        <p>In NTIS, the patient presents with a low Free T3 and a high Reverse T3, while TSH remains deceptively normal. This is the body's way of conserving energy to fuel the immune response. If a practitioner only looks at TSH, they miss this critical sign of systemic inflammatory load.</p>

        <h2 id="nutrients">4. Nutrient Synergies: The Thyroid-Immune Triad</h2>
        <p>The thyroid gland has the highest concentration of <span class="highlight">Selenium</span> of any organ in the body. Selenium is the essential cofactor for the glutathione peroxidase enzymes that protect the gland from the oxidative stress generated during thyroid hormone synthesis.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Nutrient</th>
                        <th>Thyroid Function</th>
                        <th>Immune Function</th>
                        <th>Deficiency Impact</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Selenium</strong></td>
                        <td>Cofactor for T4 to T3 conversion (Deiodinases)</td>
                        <td>Reduces TPO antibodies; supports Treg function</td>
                        <td>Increased gland inflammation; poor conversion</td>
                    </tr>
                    <tr>
                        <td><strong>Iodine</strong></td>
                        <td>Structural component of T4 and T3</td>
                        <td>Antimicrobial; supports innate immunity</td>
                        <td>Goiter; hypothyroidism; immune stagnation</td>
                    </tr>
                    <tr>
                        <td><strong>Zinc</strong></td>
                        <td>Required for T3 receptor binding in the nucleus</td>
                        <td>Thymic hormone production; T-cell maturation</td>
                        <td>Receptor resistance; frequent infections</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>A critical clinical pearl: <span class="highlight">Iodine supplementation without adequate Selenium can be dangerous</span> in Hashimoto's. Iodine increases the activity of TPO, which produces hydrogen peroxide (H2O2). Without Selenium to neutralize this H2O2, the gland suffers oxidative damage, leading to an "antibody flare."</p>

        <h2 id="testing">5. Interpreting the Full Thyroid Panel</h2>
        <p>To truly understand the thyroid-immune interplay, we must move beyond the TSH-only screening model. Within the C.A.L.M. methodology, we utilize a comprehensive panel to assess the NEI axis health.</p>

        <div class="comparison-grid">
            <div class="comparison-card conventional">
                <p class="card-label">Conventional Screening</p>
                <p class="card-text">Focuses on TSH and occasionally Free T4. Goal is to keep TSH within the 0.4â€“4.5 range. Often misses early-stage autoimmunity (Stage 1 and 2 Hashimoto's).</p>
            </div>
            <div class="comparison-card functional">
                <p class="card-label">Functional C.A.L.M. Panel</p>
                <p class="card-text">Includes TSH, Free T4, Free T3, Reverse T3, TPOAb, and TgAb. Goal is optimal ranges and a T3:rT3 ratio > 20. Identifies "cellular hypothyroidism."</p>
            </div>
        </div>

        <h3>The Importance of Antibodies (TPOAb & TgAb)</h3>
        <p>Antibodies can be present <span class="stat-highlight">7â€“10 years</span> before TSH becomes abnormal. Identifying these early allows the Autoimmune Specialist to intervene in the "A" (Address Root Causes) phase before permanent tissue destruction occurs. High antibodies are a signal of "Immune Loss of Self-Tolerance," regardless of what the TSH says.</p>

        <h2 id="calm-integration">6. C.A.L.M. Autoimmune Protocolâ„¢ Integration</h2>
        <p>How do we apply this to our framework?
        <ul class="content-list">
            <li><strong>Contain Inflammation (C):</strong> Lowering systemic cytokines (IL-1, IL-6) is the fastest way to improve T4 to T3 conversion and lower Reverse T3.</li>
            <li><strong>Address Root Causes (A):</strong> Testing for <i>Yersinia</i>, EBV, and gluten cross-reactivity to stop the molecular mimicry drive.</li>
            <li><strong>Lifestyle Medicine (L):</strong> Managing the HPA axis (cortisol) to prevent the inhibition of TSH production and conversion.</li>
            <li><strong>Maintain Remission (M):</strong> Monitoring antibody trends as a "canary in the coal mine" for potential flares.</li>
        </ul>
        </p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of the thyroid-immune axis.</p>
            
            <div class="question-item">
                <span class="question-number">1</span>
                <p class="question-text">Why might a patient with high levels of inflammation (e.g., high hs-CRP) have a high Reverse T3 level?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Inflammation upregulates the Deiodinase 3 (D3) enzyme, which shunts T4 into the inactive Reverse T3 (rT3) form instead of active T3. This is a survival mechanism to slow metabolism during illness (Non-Thyroidal Illness Syndrome).
                </div>
            </div>

            <div class="question-item">
                <span class="question-number">2</span>
                <p class="question-text">What is the clinical risk of supplementing high-dose Iodine in a patient with Selenium deficiency and Hashimoto's?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Iodine increases TPO activity, which generates hydrogen peroxide (H2O2) as a byproduct. Without Selenium (the cofactor for glutathione peroxidase), this H2O2 causes oxidative damage to the thyroid, potentially triggering an autoimmune flare and increasing TPO antibodies.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>The thyroid is the most common autoimmune target due to molecular mimicry with pathogens and food proteins.</li>
                <li>T3 is a direct immune modulator; low levels impair T-regulatory cell function and NK cell activity.</li>
                <li>Non-Thyroidal Illness Syndrome (NTIS) is an inflammatory adaptation where T3 is low and Reverse T3 is high, often with a "normal" TSH.</li>
                <li>A functional thyroid panel must include antibodies and Reverse T3 to provide a complete picture of the NEI axis.</li>
                <li>Selenium, Zinc, and Iodine must be balanced; Selenium is non-negotiable for gland protection during iodine utilization.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <p>Mancino et al. (2021). "The thyroid-immune axis: A review of the impact of thyroid hormones on immune cell function." <i>Frontiers in Endocrinology</i>.</p>
            <p>Chistiakov, D. A. (2005). "Immunogenetics of Hashimoto's thyroiditis." <i>Journal of Autoimmune Diseases</i>.</p>
            <p>Biondi et al. (2019). "The 2019 European Thyroid Association Guidelines for the Management of Subclinical Hypothyroidism." <i>European Thyroid Journal</i>.</p>
            <p>Liontiris et al. (2017). "A review of Hashimoto's thyroiditis and its connection to gut dysbiosis." <i>Hellas Journal of Nuclear Medicine</i>.</p>
            <p>Ventura et al. (2017). "Selenium and Thyroid Disease: From Pathophysiology to Treatment." <i>International Journal of Endocrinology</i>.</p>
            <p>KÃ¶hrle, J. (2015). "Selenium and the thyroid: A close-knit connection." <i>Nature Reviews Endocrinology</i>.</p>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Autoimmune Specialist Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. Proprietary C.A.L.M. Autoimmune Protocolâ„¢ Framework.</p>
        </footer>
    </div>
</body>

</html>